SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,463 | +724.5% | 25,317 | +183.3% | 0.01% | +350.0% |
Q2 2023 | $420 | +12.0% | 8,938 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $375 | +10.0% | 8,938 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $341 | -99.9% | 8,938 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $350,000 | +21.1% | 8,938 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $289,000 | -2.4% | 8,938 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $296,000 | -22.1% | 8,938 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $380,000 | -4.0% | 8,938 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $396,000 | -22.0% | 8,938 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $508,000 | -24.1% | 8,938 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $669,000 | -13.5% | 8,938 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $773,000 | +41.6% | 8,938 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $546,000 | +46.8% | 8,938 | 0.0% | 0.00% | +50.0% |
Q2 2020 | $372,000 | +44.7% | 8,938 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $257,000 | -55.5% | 8,938 | +11.9% | 0.00% | -33.3% |
Q4 2019 | $577,000 | -48.5% | 7,987 | 0.0% | 0.00% | -57.1% |
Q3 2019 | $1,120,000 | -23.4% | 7,987 | 0.0% | 0.01% | -22.2% |
Q2 2019 | $1,462,000 | -4.4% | 7,987 | -16.9% | 0.01% | -10.0% |
Q1 2019 | $1,530,000 | +130.1% | 9,617 | +38.4% | 0.01% | +100.0% |
Q4 2018 | $665,000 | -32.4% | 6,947 | -0.3% | 0.01% | -16.7% |
Q3 2018 | $984,000 | +32.1% | 6,966 | +46.4% | 0.01% | +20.0% |
Q2 2018 | $745,000 | +50.5% | 4,757 | +54.9% | 0.01% | +66.7% |
Q1 2018 | $495,000 | -2.2% | 3,072 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $506,000 | – | 3,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |